Surgeon-scientist: How we're moving the needle for head and neck cancer
The head and neck are home to so many structures like nerves and blood vessels that intimately impact function. From speaking to swallowing to breathing to facial expressions, these functions help make us who we are.
As a head and neck surgeon and researcher, I understand how head and neck cancers and their treatments can potentially impact these important functions. That’s why my team strives not only to cure patients, but...

Top 5 MD Anderson abstracts at AACR 2025
The American Association for Cancer Research (AACR) Annual Meeting showcases exciting new cancer therapies that help link translational science...
Triple-negative breast cancer survivor: Why I chose a clinical trial at MD Anderson
Cancer runs very strongly on one side of my family. Several members have had either breast cancer or ovarian cancer. Two tested positive for...
Head of Cancer Medicine: ‘MD Anderson is the place I bring my loved ones’
As a physician-scientist, I have a series of roles at MD Anderson. I’m the division head of Cancer Medicine where I oversee 16 medical oncology departments. I’m also a professor and chair of one of those departments, Lymphoma and Myeloma, where I care for patients with lymphoma and oversee research.
However, like many employees at MD Anderson, my connection to our mission goes beyond my professional roles. MD Anderson is also the...

Young adult breast cancer survivor: Why I volunteer at the Texas Children’s Houston Open
I have volunteered at the Texas Children’s Houston Open golf tournament for three of the last five years.
The first time...
Stereotactic body radiation therapy (SBRT) for prostate cancer: What to know
If you have received a prostate cancer diagnosis, you may be wondering which treatment options are available to you. Prostate cancer treatment...
Chronic myeloid leukemia survivor: Why I joined a clinical trial at MD Anderson
When I was diagnosed with chronic myeloid leukemia (CML) in 2005, I was flabbergasted. There was no history of cancer in my family. I was...
Menin inhibitor clinical trial puts pediatric leukemia patient in remission
When David Stan was diagnosed with acute myeloid leukemia in the summer of 2023, his parents, Emil and Maria, were stunned. Cancer doesn’t...
Finding hope for cancer patients in ferroptosis research
Guang Lei, M.D., Ph.D., spends his days in a lab studying ferroptosis, a type of programmed cell death.
But it’s not a love of science...
Exploring pancreatic cancer vaccines: What’s next?
When most people think of a vaccine, they think of the prevention of a disease. For pancreatic cancer vaccines, though, it’s a little bit...